Sanofi is the third company - along with J&J and Eli Lilly - to attempt to change the way it pays for medicines under the ...

Whooping cough cases are up sixfold from the same time last year in the U.S., affecting states ranging from Pennsylvania and ...

When Trump nominated the vaccine critic to lead the Health and Human Services agency, his choice rippled through the autism ...

Today's health news includes autism advocates' response to anti-vaccine sentiment and a trip to the prosthetic nipple factory ...

Opinion: Pro-vaccine advocates facing RFK Jr. are stronger, savvier, and more ready for a fight than ever before.

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured ...

Generative AI poses unique challenges to the FDA's regulatory process: from initial evaluation and review, to post market monitoring.

What happens when the Trump train hits the health care establishment? There’s no doubt that President-elect Trump’s decision to nominate Robert F. Kennedy Jr., an environmental activist and vaccine ...

In today's biotech news, Prime Editing's CEO promises aggressive defense of patents; Novartis acquires a gene editing startup, and the migration to Bluesky.

When you blocked someone on Twitter, you could no longer see them and they could no longer see you. Now when you block someone on X for malicious behavior, they can still see your posts. I prefer to ...

IVC filters, implants that prevent blood clots, aren't meant to be permanent — but doctors often forge to retrieve them.

Schrödinger is an unusual animal in the AI in drug discovery landscape. In a new interview with CEO Ramy Farid, STAT’s ...